Farmaceuticos Comunitarios最新文献_第2页

[SEFAC's 25th anniversary: consolidating evidence, planning for the future]. [SEFAC成立25周年：巩固证据，规划未来]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-10-14 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).35

引用次数: 0

[Evaluation of pharmaceutical intervention to patients in the community through telepharmacy]. [远程药房对社区患者药物干预的评价]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-10-13 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).33

G M Delgado-Pérez, X N Munayco Ortiz, J R Chipana Lujan, C E Dávila-Espinoza, V R Pizarro-Herrera

{"title":"[Evaluation of pharmaceutical intervention to patients in the community through telepharmacy].","authors":"G M Delgado-Pérez, X N Munayco Ortiz, J R Chipana Lujan, C E Dávila-Espinoza, V R Pizarro-Herrera","doi":"10.33620/FC.2173-9218.(2025).33","DOIUrl":"10.33620/FC.2173-9218.(2025).33","url":null,"abstract":"Introduction: Pharmaceutical interventions (PI) are important for the resolution of drug-related problems (DRP). An alternative to efficiently meet this need is telepharmacy, defined as a modality of pharmaceutical services provided remotely through information and communication technologies (ICT).Objectives: To evaluate PI through telepharmacy in terms of their benefit to treatment effectiveness and/or safety.Methods: Retrospective observational study. Data were obtained from the pharmacotherapeutic records of eight community pharmacies that carried out PI through telepharmacy from November 2020 to October 2021. PI were evaluated using impact codes (benefit to treatment effectiveness and/or safety).Results: A total of 21 patients participated, of whom 11 were men. The median age was 61 years (Q1-Q3: 55-67). According to the ATC code, the most prevalent drug groups were: A-Alimentary tract and metabolism (n=38; 24.2%) and C-Cardiovascular system (n=31; 19.8%). A total of 183 DRP were identified (90 potential and 93 real) and 121 PI, of which 51.2% could be evaluated (n=62; 44 PI on effectiveness and 18 PI on safety).Conclusion: The PI carried out by community pharmacists were assessable and improved both the effectiveness and safety of medications.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"94-116"},"PeriodicalIF":0.5,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Analysis of the implementation of a Professional Pharmaceutical Service in Nutrition after 12 years operation]. 【营养学专业药学服务运营12年的实施分析】。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-10-13 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).31

N Acuña Elvira

{"title":"[Analysis of the implementation of a Professional Pharmaceutical Service in Nutrition after 12 years operation].","authors":"N Acuña Elvira","doi":"10.33620/FC.2173-9218.(2025).31","DOIUrl":"10.33620/FC.2173-9218.(2025).31","url":null,"abstract":"Introduction: In 2012, a Professional Pharmaceutical Nutrition Service was implemented in a Lanzarote Pharmacy. This service offers nutritional and dietary advice and follow-up to study the evolution. After the 12 years, an analysis has been carried out including all the patients who have been part of the service.Method: With the information from the successive interviews, a quasi-experimental study has been developed in which different variables are studied, both qualitative (sex, age, diseases suffered) and quantitative (weight, height, BMI, % body fat, blood pressure values, blood glucose values, number of visits). The time frame is from March 2012 to March 2024. The study population is all the patients who attended the consultation after the implementation of the service.Results: The sample consisted of 1,638 patients. It is observed that most of the patients are women. The main objective is to lose weight in 98.7% of cases, increase weight in 0.5% and control biochemical parameters in 0.8%. After inclusion in the service, the obesity rate was reduced from 70.1% before the first intervention to 20.3% after the last consultation. Normal weight rates increased from the initial 3.1 to the final 30.2. There are statistically significant differences between the number of visits and the weight loss obtained, with more weight loss the more appointments there are. In addition, the number of symptoms and pathologies present in overweight or obese patients decreases with weight loss.Conclusions: The community pharmacy can be a key center to combat the high numbers of overweight and obesity in the population.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"81-86"},"PeriodicalIF":0.5,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[On the Basis of a Case: Follow-Up of a Patient with Chronic Obstructive Pulmonary Disease (COPD) through the EPOCA Service]. [基于一个病例：通过EPOCA服务对慢性阻塞性肺疾病（COPD）患者的随访]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-10-03 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).32

O Deleito Molina

{"title":"[On the Basis of a Case: Follow-Up of a Patient with Chronic Obstructive Pulmonary Disease (COPD) through the EPOCA Service].","authors":"O Deleito Molina","doi":"10.33620/FC.2173-9218.(2025).32","DOIUrl":"10.33620/FC.2173-9218.(2025).32","url":null,"abstract":"Abstract: 71-year-old man with multiple pathologies. He goes to the pharmacy and a frequent throat clearing and cough is detected. He says it has been going on for a couple of months. He has tried mucolytics, cough suppressants and flu medications, and nothing calms him down. As a patient with COPD, you are invited to go to the PCA.During the initial consultation, we provided health education and a spirometry test with the Vitalograph® COPD-6 (unable). We performed validated tests, reviewed the inhalation technique, device care, and cleaning, as well as the patient's medications.The patient was instructed on proper inhalation technique, as two critical errors were detected.After 6 days, he was given an appointment and the same tests were performed, obtaining acceptable FEV1/FEV6 values, COPD grade = 2, BODEX = 3 (moderate), and corrected inhalation technique, but he did not improve his sintoms.After 7 days, we performed spirometry again, COPD grade = 1, BODEX = 3. The technique still showed no critical errors, so we used the InCheckDial® to detect whether the inspiratory flow was correct, and we detected that the inspiration was too forceful (≥90 L/min).The patient was referred to the PCP for treatment assessment with a detailed report suggesting a change of inhalation device. The PCP changed the device to an Ellipta® and requested a follow-up with your pulmonologist.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"87-93"},"PeriodicalIF":0.5,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537058/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145348945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Drug Excipients. Necessary, but not Harmless]. (药物赋形剂。必要，但并非无害]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-10-01 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).30

M D López Alarcón, A Justo Hernández, P Santos Cruz

引用次数: 0

[Creation of Patient Profiles and a Screening Tool for Individuals with Pain]. [创建患者档案和疼痛个体筛选工具]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-09-23 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).29

A Morcuende Campos, D Reyes Estévez, A González Rodríguez, M E Córcoles Ferrándiz, E Merencio Naudin

{"title":"[Creation of Patient Profiles and a Screening Tool for Individuals with Pain].","authors":"A Morcuende Campos, D Reyes Estévez, A González Rodríguez, M E Córcoles Ferrándiz, E Merencio Naudin","doi":"10.33620/FC.2173-9218.(2025).29","DOIUrl":"10.33620/FC.2173-9218.(2025).29","url":null,"abstract":"Introduction: Chronic pain, affecting 20-26% of adults, has a profound impact on quality of life and generates substantial socioeconomic costs. Patient profiling enables the individualization of treatment, the identification of patient subgroups, and the design of personalized therapeutic strategies, ultimately improving outcomes and healthcare efficiency. The main objective of this study is to establish patient clusters based on pain characteristics and to develop a screening tool capable of identifying patients according to the resulting clustering model.Materials and methods: A descriptive, cross-sectional, multicenter study was conducted in patients experiencing pain who visited community pharmacies. Unsupervised clustering techniques were employed to identify patterns among patients with acute and chronic pain. These were followed by statistical analyses and supervised algorithms for the prediction and evaluation of the questionnaire. Based on these findings, a tool was developed to predict patient group membership according to the identified clusters.Results: The analysis identified four acute pain profiles and five chronic pain profiles, with subgroup 1 exhibiting the poorest outcomes in both cases. The classification model used to predict new data achieved an accuracy of 64.52% for acute pain and 85.56% for chronic pain based on the available data.Conclusions: Four patient profiles were identified in acute pain and five in chronic pain, facilitating the personalization of treatment. Community pharmacy, due to its accessibility, enables continuous follow-up, improves adherence, allows for treatment adjustments, and enhances coordination of care. The classification tool will enable patient assessment through psychometric variables, thereby improving pain management.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"41-51"},"PeriodicalIF":0.5,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145348964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Initial descriptive study on Pharmaceutical Indication in community pharmacies in Central American countries]. [中美洲国家社区药房药物适应证初步描述性研究]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-08-27 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).28

B Badilla-Baltodano, K Orellana, F Martínez-Martínez, L Martínez de Haase, L C Monge-Bogantes, A M Liere-Godoy

{"title":"[Initial descriptive study on Pharmaceutical Indication in community pharmacies in Central American countries].","authors":"B Badilla-Baltodano, K Orellana, F Martínez-Martínez, L Martínez de Haase, L C Monge-Bogantes, A M Liere-Godoy","doi":"10.33620/FC.2173-9218.(2025).28","DOIUrl":"10.33620/FC.2173-9218.(2025).28","url":null,"abstract":"Introduction: Within Good Pharmacy Practices, pharmaceutical indication is one of the most frequently requested pharmaceutical services in community pharmacies to address specific health problems as part of pharmaceutical care. This study aimed to explore the frequency and characteristics of pharmaceutical indication (PI), also known as pharmaceutical recommendation (PR), in Central American countries, specifically in private community pharmacies.Materials and methods: This was an observational, exploratory, cross-sectional study using non-probabilistic convenience sampling. An electronic questionnaire consisting of 23 closed-ended and one open-ended question was distributed to community pharmacists working in private pharmacies, that is, privately owned, non-state establishments in the region. Data from Nicaragua were excluded due to the low number of responses. The survey explored general characteristics, professional perceptions, and clinical practice. Content validation was performed with one pharmacist from each country. No personal data was collected.Results: Among the pharmacists who responded, PI/PR activities generally did not meet the common principles and reference frameworks supported by international organizations and national guidelines. Furthermore, there was considerable heterogeneity in the legislation and regulations governing this pharmaceutical service across Central America. The assessment of training received in this area revealed important opportunities for improvement.Conclusions: Community pharmacy services in the study group should be redefined within a more patient-centered, clinical model to optimize pharmacotherapy and contribute to the maintenance and improvement of individual and public health.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"23-29"},"PeriodicalIF":0.5,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145348966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Pharmaceutical Professional Services for Metabolic Syndrome. Methodology and Analysis: A Pilot Study]. 代谢综合征药物专业服务。方法学与分析：一项初步研究]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-08-14 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).22

Jaq Benítez Perdomo, S Gutierrez Moreno, A Roman Murillo, A B Fernández Rodrigo, A I Martin Martin, M E Bastos Gómez, P Caballero Campo

{"title":"[Pharmaceutical Professional Services for Metabolic Syndrome. Methodology and Analysis: A Pilot Study].","authors":"Jaq Benítez Perdomo, S Gutierrez Moreno, A Roman Murillo, A B Fernández Rodrigo, A I Martin Martin, M E Bastos Gómez, P Caballero Campo","doi":"10.33620/FC.2173-9218.(2025).22","DOIUrl":"10.33620/FC.2173-9218.(2025).22","url":null,"abstract":"Introduction: The survival of Community Pharmacy Services (CPS) within the community pharmacy (CP) model will depend on whether they are economically sustainable. Metabolic Syndrome (MS) is important for its high prevalence and significant associated morbidities. Its early detection is an excellent application of CPS with potential impact in patient outcomes.Objetives: The aim of this study is to implement a CPS to control MS in a CP using a simple diagnostic method, and to analyze its impact using health and economics indices.Materials and methods: Glucose, cholesterol, triglycerides, body mass index and blood pressure parameters were analyzed as they are the defining features of the MS. Anonymous follow-up cards were created with a total 5 sets of tests. The study results were correlated with economic indices of the CP to evaluate patient loyalty.Results: From December 2019 to December 2022, 219 valid cards were analyzed (55% women; 45% men). 94.1% of the population started the first series of tests; 25.57% continued with at least two; and only 6.85% completed the follow-up for all 5 sets of the tests. Despite a decline in the number of tests completed over the study period, there was an increase in the loyalty of users in the pharmacy, verified by the standardized indicators with an increase in the number of operations and in overall billing.Conclusions: The introduction of a CPS for self-monitoring of MS in the CP has, besides health benefits for patients, an impact on improving user loyalty and the economic results.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"3-9"},"PeriodicalIF":0.5,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Medicines use review service in community pharmacies: an open door to other clinical pharmacy services]. [社区药房的药物使用审查服务：向其他临床药学服务敞开大门]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-08-13 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).27

M Lavrador, A C Cabral, T C Lima, I V Figueiredo, M M Castel-Branco

{"title":"[Medicines use review service in community pharmacies: an open door to other clinical pharmacy services].","authors":"M Lavrador, A C Cabral, T C Lima, I V Figueiredo, M M Castel-Branco","doi":"10.33620/FC.2173-9218.(2025).27","DOIUrl":"10.33620/FC.2173-9218.(2025).27","url":null,"abstract":"Objectives: To perform a medicines use review (MUR) service and apply a methodology to tailor the patients to more complex pharmacist-led clinical services.Methods: A MUR consultation for revision with the patient of all medication to ensure the medicines are being taken properly was performed with participants from five community pharmacies. The 'Medication Adherence Universal Questionnaire' (MAUQ) and the 'Beliefs about Medicines Questionnaire' (BMQ) were added to the protocol. Medication Regimen Complexity Index (MRCI) was calculated for unintentional non-adherent patients. Then, a referral algorithm for more complex pharmacist-led clinical services - such as medication review, individualized medication preparation, or patient education - was applied to adapt a plan to each participant.Results: From the 189 patients included, 100 (52.9%) were referred to a medication review service because they used at least one high-risk medicine, presented clinically significant complaints and/or used at least 10 medicines. From the remaining, MAUQ showed 46.1% non-adherent and BMQ revealed 26.8% intentionally non-adherent, indicating the need for education/health literacy services. Within the 73.2% unintentionally non-adherent, 46.7% presented MRCI below the median value, benefiting from memory strategies or referral to individualized medication preparation, while 53.3% needed medication review. MUR resolved medicines-use issues for 48 patients and potentially benefited an additional 25.Conclusions: The MUR, combined with the assessment of medication adherence, and the subsequent application of a referral algorithm, identified patients with different needs' profiles, acting as an open door to more complex pharmacist-led services that best serve patients' needs in a community pharmacy.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"23-29"},"PeriodicalIF":0.5,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Distribution of community pharmacies and primary healthcare centers in Portugal: a cross-sectional analysis]. [葡萄牙社区药房和初级保健中心的分布：横断面分析]。

IF 0.5

Farmaceuticos Comunitarios Pub Date : 2025-08-08 eCollection Date: 2025-10-15 DOI: 10.33620/FC.2173-9218.(2025).26

L G Negrão, R Moreira, I Chaves-Neves, I V Figueiredo, F Fernandez-Llimos

{"title":"[Distribution of community pharmacies and primary healthcare centers in Portugal: a cross-sectional analysis].","authors":"L G Negrão, R Moreira, I Chaves-Neves, I V Figueiredo, F Fernandez-Llimos","doi":"10.33620/FC.2173-9218.(2025).26","DOIUrl":"10.33620/FC.2173-9218.(2025).26","url":null,"abstract":"Introduction: Poor access to community pharmacies has been associated with restricted accessibility to medicines. We aimed to compare the geographic distribution of community pharmacies and healthcare centers (HCCs) and identify sociodemographic variables associated with geographical discrepancies at the municipal level in Portugal.Methods: Data on HCC, physicians, pharmacies, and pharmacists were collected at the municipality level in 2024. Municipality population and area per healthcare establishment and professional were compared, as well as pharmacies/HCC and physician/pharmacist ratios. Multivariate analyses were conducted between dependent variables and sociodemographic factors.Results: Portugal municipalities had a mean 516 residents (SD 319) per physician and 1,021 (SD 450) per pharmacist (paired Cohen's d= 1.127 [0.76:1.277]), with a ratio physician/pharmacist of 2.55 (SD 1.55). The surface area covered by professionals was 22.0 km² (SD 35.8) per physician and 37.9 km² (SD 57.8) per pharmacist (d=0.449 [0.325:0.572]). However, population per HCC was 22,998 (SD 22,038) while 3,206 (SD 1,087) per pharmacy (d=0.924 [0.783:1.064]) and the area covered was 82.2 km² (SD 98.3) per pharmacy and 304.6 km² (SD 287.1) per HCC (d= 0.912 [0.771:1.051]). Positive associations were found between the ratio pharmacies/HCC and percentage of young population, higher educational level, or literacy.Conclusion: Despite the greater number of physicians than pharmacists, community pharmacies showed a more intensive coverage of Portuguese mainland territory when compared to HCCs. The wider dispersion of pharmacies may facilitate the role of pharmacists as public health agents.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"10-22"},"PeriodicalIF":0.5,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0